Strumento inattivo

Altre lingue Exicure Inc Other OTC

Azioni

US30205M1018

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-K	22/04
North American Morning Briefing : Stocks Struggle After New Records	22/03
An unknown buyer agreed to acquire 39.3% stake in Exicure, Inc. from DGP Co.,Ltd. for KRW 6 billion.	29/02
Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis	05/02
Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis	05/02
Wall Street Set to Open Lower Friday; Employment Growth Tops Forecasts	08/12
Investors Look Ahead to Economic Indicators as US Futures Trend Lower in Friday's Premarket	08/12
Top Premarket Gainers	08/12
Exicure : Non-Reliance on Previously Issued Financial Report - Form 8-K	01/12
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q	28/11
Northwestern University Notifies Exicure, Inc. that it Was Terminating the 2014 License	06/10/23
Exicure, Inc. Appoints Minhee Eom to the Board	27/09/23
Exicure Appoints New CEO, CFO	23/08/23
Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors	23/08/23
Exicure, Inc. Announces Executive Changes	23/08/23
Exicure, Inc. Announces Chief Financial Officer Changes	23/08/23
Exicure, Inc. Announces Executive Changes	23/08/23
Exicure : Announces Appointment of New CEO and CFO and Changes to Board of Directors - Form 8-K	23/08/23
Exicure Inc Provides Information to Shareholders	23/08/23
North American Morning Briefing : China Trouble Hits Sentiment	18/08/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Exicure Inc Other OTC

Azioni

US30205M1018

Altre lingue

Filtri